Niemann-Pick type C (NPC)
Fostering collaborative research for rare genetic disease: the example of niemann-pick type C disease
11
Evolution of structural neuroimaging biomarkers in a series of adult patients with Niemann-Pick type C under treatment
7
Deficiency of Niemann-Pick Type C-1 Protein Impairs Release of Human Immunodeficiency Virus Type 1 and Results in Gag Accumulation in Late Endosomal/Lysosomal Compartments
14
Ataxia, dystonia and myoclonus in adult patients with Niemann-Pick type C
8
Longitudinal assessment of reflexive and volitional saccades in Niemann-Pick Type C disease during treatment with miglustat
8
Size and Shape of the Corpus Callosum in Adult Niemann Pick Type C Reflects State and Trait Illness Variables
7
Proteomics of the corpus callosum to identify novel factors involved in hypomyelinated Niemann-Pick Type C disease mice
11
Atypical multisensory integration in Niemann Pick type C disease towards potential biomarkers
13
Visualization of cholesterol deposits in lysosomes of Niemann-Pick type C fibroblasts using recombinant perfringolysin O
16
Cognitive impairment profile in adult patients with Niemann pick type C disease
10
New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat
11
Phenotypic variability of Niemann-Pick disease type C including a case with clinically pure schizophrenia: a case report
6
Subcortical Volumetric Reductions in Adult Niemann Pick Disease Type C: A Cross Sectional Study
7
Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators
11
Consensus clinical management guidelines for Niemann-Pick disease type C
19
Loss of amyloid precursor protein exacerbates early inflammation in Niemann-Pick disease type C
15
Complement is dispensable for neurodegeneration in Niemann-Pick disease type C
8
Niemann Pick C1 Is Essential for Ebolavirus Replication and Pathogenesis In Vivo
12
Miglustat in Niemann-Pick disease type C patients: a review
21
Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis
16